Skip to content

Researchers identify previously unknown cell-type in the mouse retina.

Neurons are nerve cells involved in receiving or sending signals. Excitatory and inhibitory neurons in the CNS are distinguished by several features, including morphology, transmitter content, and synapse architecture.  Such distinctions are exemplified in the vertebrate retina, with the retina well-mapped, and for the past 100 years scientists placing retinal interneurons squarely into one of two boxes.  Now, a study from researchers at University of Washington identifies a previously unknown type of neuron, that falls outside century-old classifications, in the retina of mice.  The team state that the new cell, which they have named GluMI (pronounced gloomy), acts like one class of neurons but anatomically resembles another.  The opensource study is published in the journal Current Biology.

Previous studies show that bipolar neurons relay information from the retina’s photoreceptors, which capture light, to the specialized cells that process those signals into vision for the brain, called ganglion cells. Monopolar neurons, on the other hand, typically aren’t contacted directly by photoreceptors. They also provide inhibition, meaning they hit the brakes to keep nerve cell signaling traffic in check.  Earlier studies from the lab identified the GluMIs in 2010, while studying the retina of transgenic mice. These animals were engineered to manufacture a fluorescent protein to help illuminate different cells in different colors.  The group observed a cell type that looked monopolar but, puzzlingly, didn’t have any of the markers of an inhibitory retinal cell.  The current study clarifies the appearance and function of the GluMI cell, whose structure is monopolar, yet acts like a bipolar cell by exciting the ganglion cells.

The current study utilises 3-D images to show that the glutamatergic monopolar interneuron, or GluMI, was relaying light information and showed that its light responses differed from those of bipolar cells. The researchers note that since the new cell isn’t contacted by the photoreceptors, the source of these light responses is a mystery.

Data findings show that the GluMIs do not receive direct photoreceptor input, and their light responses are strongly shaped by both ON and OFF pathway-derived inhibitory input. Results show that GluMIs contact and make almost as many synapses as bipolar cells onto retinal ganglion cells. The lab state that, however, GluMIs and bipolar cells possess functionally distinct light-driven responses and may therefore mediate separate components of the excitatory synaptic input to retinal ganglion cells.

The team surmise that the identification of GluMIs unveils a novel cellular component of excitatory circuits in the vertebrate retina, underscoring the complexity in defining cell types even in this well-characterized region of the CNS.  For the future, the researchers state that although they didn’t intend to find it, they look forward to exploring the role of the GluMI cell in visual function, in conjunction with the rest of the global medical community.

Source: University of  Washington Department of Biological Structure

 

3-D reconstruction of a GluMI cell at the ultrastructural level showing its input (magenta puncta) and output (yellow puncta) obtained using serial block face scanning electron microscopy.  Credit: Takeshi Yoshimatsu.
3-D reconstruction of a GluMI cell at the ultrastructural level showing its input (magenta puncta) and output (yellow puncta) obtained using serial block face scanning electron microscopy. Credit: Takeshi Yoshimatsu.

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »